Bioclonetics Inc entered the industry of Commercial Medical Research in 1989 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Joseph Cotropia by calling (337) 836-1478 during business hours. You can also write to the business’ Single Location at 921 South 8th St, Philadelphia, Pennsylvania PA 19147. You can also visit the company’s website at bioclonetics.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Bioclonetics Inc |
| Representative: | Joseph Cotropia |
| Place of Business: | 921 South 8th St, Philadelphia, PA 19147 |
| Contact Number: | (337) 836-1478 |
| Website: | bioclonetics.com |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1989 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Bioclonetics Inc is a company operating from Philadelphia, Pennsylvania providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1989 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Bioclonetics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Joseph Cotropia at (337) 836-1478 for related queries, or to locate its Single Location using the coordinates 39.9377,-75.156318.
The Single Location can also be found at the street address 921 South 8th St in Philadelphia, Pennsylvania 19147 and can be engaged online through the company website at bioclonetics.com, the company Twitter , and Facebook page .